Stay updated with breaking news from 4bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press Release 4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics 16 November 2022 London & New York - 4BIO Capital("Kriya"), a fully integrated gene
Press Release 4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing 7 June 2022 London & Greater Philadelphia - 4BIO Capital
Press Release 4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology Collaboration
Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON - 4BIO Capital ("4BIO" or "the Group"), an international venture capital
4BIO Capital Announces Strategic Partnership with Harbor Capital Advisors 4BIO Capital appointed as highly specialized asset manager for Harbor's disruptive innovation strategy after competitive manager